The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Clinical trial NCT05284851 · UNKNOWN

Trial details

NCT number: NCT05284851
Sponsor: Changchun BCHT Biotechnology Co.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Prevention

Start date: 2022-04-01
Primary completion: 2022-05-01
Enrollment: 2520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.